Encellin Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 10
Employees
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $5.9M
Latest Deal Amount
  • Investors
  • 9

Encellin General Information

Description

Operator of a biotechnology company intended to develop a novel thin-film cell encapsulation device for cell-based therapeutics. The company's device uses thin-film cell delivery technology that assists to encapsulate and replace the cells responsible for making insulin, enabling patients to manage their disease and have better control over their blood glucose levels.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Primary Office
  • 338 Spear Street
  • Unit 11F
  • San Francisco, CA 94105
  • United States

Encellin Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Encellin Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round 05-Aug-2021 $5.9M 00.000 Completed Clinical Trials - General
4. Early Stage VC 00.000 Completed Clinical Trials - General
3. Seed Round 19-Jul-2019 00.000 00.000 000.00 Completed Clinical Trials - General
2. Accelerator/Incubator 01-Jan-2019 $150K $150K 00.000 Completed Clinical Trials - General
1. Grant 06-Apr-2017 $10K Completed Clinical Trials - General
To view Encellin’s complete valuation and funding history, request access »

Encellin Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-2 000,000 00.000000 00.00 00.00 00 00.00 0.000
Seed-1 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view Encellin’s complete cap table history, request access »

Encellin Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a biotechnology company intended to develop a novel thin-film cell encapsulation device for cell-based thera
Therapeutic Devices
San Francisco, CA
10 As of 2021
00.000
000000000 00.000

0000000

eniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute
00000000000 0000000
Germantown, MD
00 As of 0000
000.00
00000000000 000.00

0000000

t dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut al
0000 000000000
San Diego, CA
000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Encellin Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Seraxis Venture Capital-Backed Germantown, MD 00 000.00 00000000000 000.00
0000000 Venture Capital-Backed San Diego, CA 000 00000 00000000000 00000
0000000 Venture Capital-Backed Boston, MA 00 00000 000000000 00000
You’re viewing 3 of 3 competitors. Get the full list »

Encellin Patents

Encellin Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020234820-A1 Cell encapsulation devices and methods of using same Pending 11-Mar-2019 000000000

Encellin Executive Team (4)

Name Title Board Seat Contact Info
Crystal Nyitray Ph.D Co-Founder, President, Chief Executive Officer and Board Member
Grace Wei Ph.D Chief Operating Officer, Co-Founder & Board Member
Tejal Desai Ph.D Co-Founder & Technology Expert
Ronald Martell Co-Founder, Executive Chairman & Board Member
To view Encellin’s complete executive team members history, request access »

Encellin Board Members (3)

Name Representing Role Since
Consuelo Valverde SV Latam Capital Board Member 000 0000
Crystal Nyitray Ph.D Encellin Co-Founder, President, Chief Executive Officer and Board Member 000 0000
Ronald Martell Self Co-Founder, Executive Chairman & Board Member 000 0000
To view Encellin’s complete board members history, request access »

Encellin Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Encellin Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Evolution VC Partners Venture Capital Minority 000 0000 000000 0
Khosla Ventures Venture Capital Minority 000 0000 000000 0
Sand Hill Angels Angel Group Minority 000 0000 000000 0
SV Latam Capital Venture Capital Minority 000 0000 000000 0
Y Combinator Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »